| abstract |
Disclosed is an attenuation method utilizing an opioid antagonist of endothelial cell migration and / or endothelial cell proliferation, in particular, endothelial cell migration and / or endothelial cell proliferation associated with a tumor. The present invention relates to endothelial cell proliferation and endothelium which may be related to cell proliferation and cell migration, particularly angiogenesis, which may be, but are not limited to, peripherally localized antagonists. Methods are provided for attenuating, eg, inhibiting or reducing cell migration. [Selection] Figure 1 |